These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21971665)
1. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Zhou X; Zhao F; Wang ZN; Song YX; Chang H; Chiang Y; Xu HM Oncol Rep; 2012 Feb; 27(2):447-54. PubMed ID: 21971665 [TBL] [Abstract][Full Text] [Related]
2. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer. Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis. Gong L; Wang C; Gao Y; Wang J Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma. Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808 [TBL] [Abstract][Full Text] [Related]
6. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer. Ling S; Ruiqin M; Guohong Z; Ying W Eur J Gynaecol Oncol; 2015; 36(4):463-8. PubMed ID: 26390704 [TBL] [Abstract][Full Text] [Related]
8. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788 [TBL] [Abstract][Full Text] [Related]
9. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes. Pan L; Meng Q; Li H; Liang K; Li B Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677 [TBL] [Abstract][Full Text] [Related]
10. Suppressive Role of MicroRNA-148a in Cell Proliferation and Invasion in Ovarian Cancer Through Targeting Transforming Growth Factor-β-Induced 2. Zhao M; Su Z; Zhang S; Zhuang L; Xie Y; Li X Oncol Res; 2016; 24(5):353-360. PubMed ID: 27712592 [TBL] [Abstract][Full Text] [Related]
11. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. Yuan J; Wang K; Xi M Med Sci Monit; 2016 Feb; 22():617-24. PubMed ID: 26908019 [TBL] [Abstract][Full Text] [Related]
12. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1. Jin M; Yang Z; Ye W; Xu H; Hua X PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Cao Q; Lu K; Dai S; Hu Y; Fan W Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene. Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Peng DX; Luo M; Qiu LW; He YL; Wang XF Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341 [TBL] [Abstract][Full Text] [Related]
17. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. Chen Y; Song Y; Wang Z; Yue Z; Xu H; Xing C; Liu Z J Gastrointest Surg; 2010 Jul; 14(7):1170-9. PubMed ID: 20422307 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1. Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer. Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]